SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 02/03/2026 at 07:05, 4 days 18 hours ago

Sanofi Signs €1 Billion Share Buyback Mandate

Share Buyback Investment Financial Strategy Biopharma Sanofi
PRESS RELEASE

published on 02/03/2026 at 07:00, 4 days 18 hours ago

Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
Sanofi signs share buyback mandate for up to €1 billion, intending to repurchase own shares between February 3, 2026, and December 31, 2026

Share Buyback Investment Sanofi Mandate €1 Billion
BRIEF

published on 01/30/2026 at 13:05, 8 days 12 hours ago

The CHMP recommends approval of Sanofi's Rezurock for the treatment of chronic GVHD

Treatment Sanofi Rezurock CHAMP GVHD
BRIEF

published on 01/30/2026 at 13:05, 8 days 12 hours ago

Sanofi's Rezurock Recommended for EU Approval by CHMP

Sanofi EU Market CHMP Approval Rezurock Chronic GVHD
PRESS RELEASE

published on 01/30/2026 at 13:00, 8 days 12 hours ago

Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
Sanofi's Rezurock recommended for EU approval by the CHMP for chronic graft-vs-host disease treatment, based on clinical studies. New treatment option for patients

Sanofi EU Approval CHMP Recommendation Rezurock Chronic GVHD
BRIEF

published on 01/23/2026 at 07:05, 15 days 18 hours ago

Sanofi's Amlitelimab Shows Promise in Atopic Dermatitis Treatment

Sanofi Atopic Dermatitis Phase 3 Studies Amlitelimab Regulatory Submissions
PRESS RELEASE

published on 01/23/2026 at 07:00, 15 days 18 hours ago

Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis
Sanofi's amlitelimab shows potential in atopic dermatitis with positive results in SHORE and COAST 2 phase 3 studies. Global regulatory submissions planned

Sanofi Phase 3 Study Atopic Dermatitis Global Regulatory Submissions Amlitelimab
BRIEF

published on 12/24/2025 at 07:20, 1 month 14 days ago

Sanofi to Acquire Dynavax, Expanding Vaccine Portfolio

Sanofi Acquisition Dynavax Technologies HEPLISAV-B® Vaccine Shingles Candidate Adult Immunization
PRESS RELEASE

published on 12/24/2025 at 07:15, 1 month 14 days ago

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
Sanofi announces acquisition of Dynavax Technologies Corporation, expanding adult vaccine portfolio with hepatitis B and shingles candidates. Merger valued at $2.2 billion

Acquisition Sanofi Vaccines Dynavax Hepatitis B
BRIEF

published on 12/24/2025 at 07:05, 1 month 14 days ago

Sanofi Faces Delay in FDA Approval for Tolebrutinib in MS Treatment

FDA Sanofi Tolebrutinib MS Treatment Regulatory Delay

Accesswire

Published on 02/07/2026 at 01:00, 1 day ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 2 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 3 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 10 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 12 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 4 hours 41 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 9 hours 5 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 9 hours 20 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 6 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 7 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 7 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 9 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 6 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 7 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 7 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE